Wnt10b protects cardiomyocytes against doxorubicin-induced cell death via MAPK modulation.

Saved in:
Bibliographic Details
Title: Wnt10b protects cardiomyocytes against doxorubicin-induced cell death via MAPK modulation.
Authors: Chen L; Department of Cardiovascular Medicine, University of Kansas School of Medicine, Kansas City, KS, United States of America., Byer SH; Department of Cardiovascular Medicine, University of Kansas School of Medicine, Kansas City, KS, United States of America., Holder R; Department of Cardiovascular Medicine, University of Kansas School of Medicine, Kansas City, KS, United States of America., Wu L; Department of Cardiovascular Medicine, University of Kansas School of Medicine, Kansas City, KS, United States of America., Burkey K; Department of Cardiovascular Medicine, University of Kansas School of Medicine, Kansas City, KS, United States of America., Shah Z; Department of Cardiovascular Medicine, University of Kansas School of Medicine, Kansas City, KS, United States of America.
Source: PloS one [PLoS One] 2023 Oct 19; Vol. 18 (10), pp. e0277747. Date of Electronic Publication: 2023 Oct 19 (Print Publication: 2023).
Publication Type: Journal Article
Journal Info: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1932-6203
DOI:10.1371/journal.pone.0277747